Combination of the PAM4 and CA19-9 biomarkers to improve the detection of pancreatic adenocarcinoma.
David V. Gold
No relevant relationships to disclose
Jochen Gaedcke
No relevant relationships to disclose
B. Michael Ghadimi
No relevant relationships to disclose
Michael Goggins
No relevant relationships to disclose
Ralph H. Hruban
No relevant relationships to disclose
Mengling Liu
No relevant relationships to disclose
Guy Newsome
No relevant relationships to disclose
David M. Goldenberg
Employment or Leadership Position - Immunomedics
Stock Ownership - Immunomedics